Expression and functional proteomics studies in colorectal cancer

Area of Science:

• Molecular biology and oncology, focusing on proteomics in colorectal cancer (CRC) research.

Background:

• Cellular dysfunction in most colorectal cancers (CRC) arises from complex gene interactions, not single genes.
• Proteins, as the functional molecules, exhibit a non-linear relationship with mRNA gene expression levels.
• Post-translational modifications and protein isoforms, crucial in disease, are detectable through proteomics.

Purpose of the Study:

• To highlight the complementary role of proteomics to genetic approaches in CRC research.
• To review the application of proteomics in understanding CRC at the molecular and cellular levels.
• To emphasize the potential of proteomics in advancing personalized medicine for CRC.

Main Methods:

• Expression proteomics studies utilizing colorectal cell lines, whole tissue biopsies, and purified epithelial cells.
• Development and utilization of CRC-specific two-dimensional electrophoresis reference maps and protein databases.
• Functional proteomics to investigate signaling pathways, drug targets, and tumor-associated antigens.

Main Results:

• Proteomics enables the detection of post-translational modifications and disease-relevant protein isoforms.
• Available proteomics resources (databases, reference maps) facilitate CRC research.
• Functional proteomics studies have elucidated signaling pathways and identified potential therapeutic targets in CRC.

Conclusions:

• Proteomics provides critical insights into CRC pathogenesis that are inaccessible through genetic analysis alone.
• The integration of proteomics technologies is essential for a comprehensive understanding of CRC.
• Advancements in proteomics will accelerate the development of personalized medicine strategies for colorectal cancer.